Scott D Larsen
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 09, 2020
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.Michael W Wilson, Liming Shu, Vania Hinkovska-Galcheva
|Feb 11, 2020
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds.Erika M Lisabeth, Dylan Kahl, Indiwari Gopallawa
|Feb 07, 2020
Discovery and Optimization of Triazine Nitrile Inhibitors of <i>Toxoplasma gondii</i> Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNS.Jeffery D Zwicker, David Smith, Alfredo J Guerra
|Jun 13, 2019
Correction to "Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine".Helen V Waldschmidt, Kristoff T Homan, Marilyn C Cato
|Apr 06, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma.Dylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth
|Sep 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.Brandt C Huddle, Edward Grimley, Cameron D Buchman
Pageof 2
